These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33565654)

  • 41. A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.
    Wataya-Kaneda M; Tanaka M; Nakamura A; Matsumoto S; Katayama I
    Br J Dermatol; 2011 Oct; 165(4):912-6. PubMed ID: 21692771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.
    Balestri R; Neri I; Patrizi A; Angileri L; Ricci L; Magnano M
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):14-20. PubMed ID: 25174683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significant cases of central cusps, enamel pits, and oral fibromas in tuberous sclerosis complex.
    Taga H; Yonenaga K; Eno Y; Yasumitsu T; Hatano T; Matsuo A; Takato T
    Odontology; 2021 Jan; 109(1):279-283. PubMed ID: 32720211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coexistence of two neurocutaneous syndromes: tuberous sclerosis and hypomelanosis of Ito.
    Muhammed K; Mathew J
    Indian J Dermatol Venereol Leprol; 2007; 73(1):43-5. PubMed ID: 17314448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex.
    Guo Y; Dreier JR; Cao J; Du H; Granter SR; Kwiatkowski DJ
    PLoS One; 2016; 11(12):e0167384. PubMed ID: 27907099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
    Li S; Takeuchi F; Wang JA; Fuller C; Pacheco-Rodriguez G; Moss J; Darling TN
    J Exp Med; 2005 Sep; 202(5):617-24. PubMed ID: 16129702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TSC2/PKD1 contiguous gene syndrome: a report of 2 cases with emphasis on dermatopathologic findings.
    Kacerovska D; Vrtel R; Michal M; Vanecek T; Vodicka R; Kreuzberg B; Ricarova R; Pizinger K; Danis D; Reischig T; Kazakov DV
    Am J Dermatopathol; 2009 Aug; 31(6):532-41. PubMed ID: 19590422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of MLH-1 and psoriasin genes in cutaneous angiofibromas from tuberous sclerosis complex patients.
    La Placa M; Gibellini D; Bianchi T; Patrizi A
    J Cutan Pathol; 2006 Sep; 33(9):608-13. PubMed ID: 16965334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibroma-like PEComa: A Tuberous Sclerosis Complex-related Lesion.
    Larque AB; Kradin RL; Chebib I; Nielsen GP; Selig MK; Thiele EA; Stemmer-Rachamimov A; Bredella MA; Kurzawa P; Deshpande V
    Am J Surg Pathol; 2018 Apr; 42(4):500-505. PubMed ID: 29324470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unilateral multiple facial angiofibromas: a case report with brief review of literature.
    Gutte R; Khopkar U
    Indian J Dermatol; 2013 Mar; 58(2):159. PubMed ID: 23716831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tuberous Sclerosis.
    Amorim BDB; Azulay D; Ramos-E-Silva M
    Skinmed; 2021; 19(3):179-185. PubMed ID: 34303387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
    Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
    Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.
    Koenig MK; Bell CS; Hebert AA; Roberson J; Samuels JA; Slopis JM; Tate P; Northrup H;
    JAMA Dermatol; 2018 Jul; 154(7):773-780. PubMed ID: 29800048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.
    Wataya-Kaneda M; Ohno Y; Fujita Y; Yokozeki H; Niizeki H; Ogai M; Fukai K; Nagai H; Yoshida Y; Hamada I; Hio T; Shimizu K; Murota H
    JAMA Dermatol; 2018 Jul; 154(7):781-788. PubMed ID: 29800026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative Effects of Topical 0.2% Sirolimus for Angiofibromas in Adults and Pediatric Patients with Tuberous Sclerosis Complex.
    Lee YI; Lee JH; Kim DY; Chung KY; Shin JU
    Dermatology; 2018; 234(1-2):13-22. PubMed ID: 29925060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients.
    Malissen N; Vergely L; Simon M; Roubertie A; Malinge MC; Bessis D
    J Am Acad Dermatol; 2017 Sep; 77(3):464-472.e3. PubMed ID: 28502378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clinical Trial.
    Wataya-Kaneda M; Nakamura A; Tanaka M; Hayashi M; Matsumoto S; Yamamoto K; Katayama I
    JAMA Dermatol; 2017 Jan; 153(1):39-48. PubMed ID: 27837201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients.
    Foster RS; Bint LJ; Halbert AR
    Australas J Dermatol; 2012 Feb; 53(1):52-6. PubMed ID: 22309333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficacy and safety of topical rapamycin-calcitriol for facial angiofibromas in patients with tuberous sclerosis complex: a prospective, double-blind, randomized clinical trial.
    Chen PL; Hong JB; Shen LJ; Chen YT; Wang SJ; Liao YH
    Br J Dermatol; 2020 Oct; 183(4):655-663. PubMed ID: 32064596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genital angiofibromas in tuberous sclerosis: two cases.
    Nico MM; Ito LM; Valente NY
    J Dermatol; 1999 Feb; 26(2):111-4. PubMed ID: 10091481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.